Frequently Asked Questions: MHRA and JCVI guidance on AstraZeneca COVID-19 vaccine and very rare clotting disorders

Document first published:
Page updated:
Topic:
,
Publication type:

This document should be read alongside the operational note of 7 April, the JCVI advice and the MHRA advice.